Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEQ Block vs Morphine for Analgesia in Acetabular Surgeries
NCT04688814Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Alexandria University. Primary endpoint: Total postoperative morphine consumption at 24 hours. Started Dec 2020; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04688814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688814.